We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Invacare (IVC) Introduces TDX SP2 Power Wheelchair Globally
Read MoreHide Full Article
Invacare Corporation recently announced the global launch of its proprietary Invacare TDX SP2 Power Wheelchair. The branded wheelchair comes equipped with LiNX Technology and Motion Concepts Ultra Low Maxx Positioning System.
The new LiNX technology allows high-end complex rehabilitation needs to be met with exceptional functionality and ease of use. The LiNX electronics system includes a touch screen display, wireless programming and remote monitoring. All this helps with better clinical evaluations, easy, intuitive programming and seamless connected functionality for providers.
Invacare would produce the aforementioned series of wheelchairs for the North American market at its Taylor Street manufacturing facility in Elyria, OH. For European customers, the product will be assembled in Germany. The TDX SP2 power wheelchair base is built on several of Invacare’s core patented technologies, including SureStep suspension, Stability Lock and G-Trac tracking technology.
Going forward, we believe that the TDX SP2 wheelchair with LiNX technology should help enable long-term revenue growth for the company. Shares of Invacare have gained 1.9% in the last one month against the industry’s 5.5% decline.
Invacare is a leading manufacturer and distributor of medical equipment used in non-acute care settings. The company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. It provides medical device solutions for congenital, acquired and degenerative ailments. The company sells its products principally to home medical equipment providers through retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific.
Zacks Rank and Key Picks
Currently, Invacare has a Zacks Rank #3 (Hold).
A few better-ranked stocks in the broader medical sector are Edwards Lifesciences Corporation (EW - Free Report) , Fresenius Medical Care Corporation (FMS - Free Report) and IDEXX Laboratories, Inc. (IDXX - Free Report) .
Edwards Lifesciences has a long-term expected earnings growth rate of 15.2%. Notably, the stock has returned 5.5% over the last three months.
Fresenius Medical has yielded a strong return of 8.3% year to date. The stock has a long-term expected earnings growth rate of 10%.
IDEXX Laboratories has a long-term expected earnings growth rate of 19.8%. Additionally, the stock represents an impressive one-year return of 39.3%.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early. See Zacks' 3 Best Stocks to Play This Trend >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Invacare (IVC) Introduces TDX SP2 Power Wheelchair Globally
Invacare Corporation recently announced the global launch of its proprietary Invacare TDX SP2 Power Wheelchair. The branded wheelchair comes equipped with LiNX Technology and Motion Concepts Ultra Low Maxx Positioning System.
The new LiNX technology allows high-end complex rehabilitation needs to be met with exceptional functionality and ease of use. The LiNX electronics system includes a touch screen display, wireless programming and remote monitoring. All this helps with better clinical evaluations, easy, intuitive programming and seamless connected functionality for providers.
Invacare would produce the aforementioned series of wheelchairs for the North American market at its Taylor Street manufacturing facility in Elyria, OH. For European customers, the product will be assembled in Germany. The TDX SP2 power wheelchair base is built on several of Invacare’s core patented technologies, including SureStep suspension, Stability Lock and G-Trac tracking technology.
Going forward, we believe that the TDX SP2 wheelchair with LiNX technology should help enable long-term revenue growth for the company. Shares of Invacare have gained 1.9% in the last one month against the industry’s 5.5% decline.
Invacare is a leading manufacturer and distributor of medical equipment used in non-acute care settings. The company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. It provides medical device solutions for congenital, acquired and degenerative ailments. The company sells its products principally to home medical equipment providers through retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific.
Zacks Rank and Key Picks
Currently, Invacare has a Zacks Rank #3 (Hold).
A few better-ranked stocks in the broader medical sector are Edwards Lifesciences Corporation (EW - Free Report) , Fresenius Medical Care Corporation (FMS - Free Report) and IDEXX Laboratories, Inc. (IDXX - Free Report) .
Notably, Edwards Lifesciences and Fresenius Medical sport a Zacks Rank #1 (Strong Buy), while IDEXX Laboratories has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Edwards Lifesciences has a long-term expected earnings growth rate of 15.2%. Notably, the stock has returned 5.5% over the last three months.
Fresenius Medical has yielded a strong return of 8.3% year to date. The stock has a long-term expected earnings growth rate of 10%.
IDEXX Laboratories has a long-term expected earnings growth rate of 19.8%. Additionally, the stock represents an impressive one-year return of 39.3%.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early. See Zacks' 3 Best Stocks to Play This Trend >>